MassMutual Private Wealth & Trust’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-267	Closed	-$7.6K	–	750
2019 Q1	$7.6K	Hold	267	–	–	﹤0.01%	632
2018 Q4	$6.2K	Sell	267 -266	-50%	-$7.26K	﹤0.01%	633
2018 Q3	$18.4K	Hold	533	–	–	﹤0.01%	514
2018 Q2	$17.4K	Hold	533	–	–	﹤0.01%	521
2018 Q1	$17.5K	Hold	533	–	–	﹤0.01%	526
2017 Q4	$15.2K	Buy	533 +110	+26%	+$3.08K	﹤0.01%	561
2017 Q3	$12.3K	Hold	423	–	–	﹤0.01%	729
2017 Q2	$10.2K	Hold	423	–	–	﹤0.01%	732
2017 Q1	$9.81K	Hold	423	–	–	﹤0.01%	709
2016 Q4	$7.79K	Buy	+423	New	+$8.44K	﹤0.01%	495
2016 Q2	$4.46K	Hold	248	–	–	﹤0.01%	580
2016 Q1	$4.72K	Hold	248	–	–	﹤0.01%	640
2015 Q4	$7.2K	Buy	+248	New	+$7.16K	﹤0.01%	524
2015 Q2	–	Sell	-248	Closed	-$8.14K	–	745
2015 Q1	$8.14K	Buy	+248	New	+$7.58K	﹤0.01%	531

Other funds holding BBC

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MassMutual Private Wealth & Trust's BBC Position: Q2 2019 in Review

MassMutual Private Wealth & Trust sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2019, closing a stake of 267 shares — an estimated $7.6K sold.

MassMutual Private Wealth & Trust first reported a position in BBC in Q1 2015 and held it in 14 quarters. The position peaked at $18.4K in Q3 2018. 14 funds tracked by Wall St. Rank hold BBC as of Q2 2019.

MassMutual Private Wealth & Trust reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2019 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 267 Virtus Biotech Clinical Trials ETF shares in Q2 2019, an estimated $7.6K.
MassMutual Private Wealth & Trust first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2015 and held it in 14 quarters.
MassMutual Private Wealth & Trust's Virtus Biotech Clinical Trials ETF position peaked at $18.4K in Q3 2018.
14 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2019.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2019, filed 14 Aug 2019.